Merck & Co. Brings Daiichi In As Partner On DLL3-Targeting T-Cell Engager

 
• By Jessica Merrill
  
Merck and Daiichi are interested in testing combinations with MK-6070 • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business